|
1
|
Pui CH and Evans WE: Treatment of acute
lymphoblastic leukemia. N Engl J Med. 354:166–178. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Durinck K, Goossens S, Peirs S, Wallaert
A, Van Loocke W, Matthijssens F, Pieters T, Milani G, Lammens T,
Rondou P, et al: Novel biological insights in T-cell acute
lymphoblastic leukemia. Exp Hematol. 43:625–639. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pui CH, Robison LL and Look AT: Acute
lymphoblastic leukaemia. Lancet. 371:1030–1043. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Patrick K and Vora A: Update on biology
and treatment of T-cell acute lymphoblastic leukaemia. Curr Opin
Pediatr. 27:44–49. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Vitale A, Guarini A, Chiaretti S and Foà
R: The changing scene of adult acute lymphoblastic leukemia. Curr
Opin Oncol. 18:652–659. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Evans WE and Relling MV: Moving towards
individualized medicine with pharmacogenomics. Nature. 429:464–468.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kinlen L: Infections and immune factors in
cancer: The role of epidemiology. Oncogene. 23:6341–6348. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hilden JM, Dinndorf PA, Meerbaum SO,
Sather H, Villaluna D, Heerema NA, McGlennen R, Smith FO, Woods WG,
Salzer WL, et al: Analysis of prognostic factors of acute
lymphoblastic leukemia in infants: Report on CCG 1953 from the
Children's Oncology Group. Blood. 108:441–451. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pieters R, Schrappe M, De Lorenzo P, Hann
I, De Rossi G, Felice M, Hovi L, LeBlanc T, Szczepanski T, Ferster
A, et al: A treatment protocol for infants younger than 1 year with
acute lymphoblastic leukaemia (Interfant-99): An observational
study and a multicentre randomised trial. Lancet. 370:240–250.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kobayashi K, Sato K, Kida T, Omori K, Hori
M, Ozaki H and Murata T: Stromal cell-derived factor-1alpha/C-X-C
chemokine receptor type 4 axis promotes endothelial cell barrier
integrity via phosphoinositide 3-kinase and Rac1 activation.
Arterioscler Thromb Vasc Biol. 34:1716–1722. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yasuoka H, Tsujimoto M, Yoshidome K,
Nakahara M, Kodama R, Sanke T and Nakamura Y: Cytoplasmic CXCR4
expression in breast cancer: Induction by nitric oxide and
correlation with lymph node metastasis and poor prognosis. BMC
Cancer. 8:3402008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kirui JK, Xie Y, Wolff DW, Jiang H, Abel
PW and Tu Y: Gbetagamma signaling promotes breast cancer cell
migration and invasion. J Pharmacol Exp Ther. 333:393–403. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Raman D, Sobolik-Delmaire T and Richmond
A: Chemokines in health and disease. Exp Cell Res. 317:575–589.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Drury LJ, Ziarek JJ, Gravel S, Veldkamp
CT, Takekoshi T, Hwang ST, Heveker N, Volkman BF and Dwinell MB:
Monomeric and dimeric CXCL12 inhibit metastasis through distinct
CXCR4 interactions and signaling pathways. Proc Natl Acad Sci USA.
108:17655–17660. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Konoplev S, Lin P, Yin CC, Lin E, González
Nogueras GM, Kantarjian HM, Andreeff M, Medeiros LJ and Konopleva
M: CXC chemokine receptor 4 expression, CXC chemokine receptor 4
activation, and wild-type nucleophosmin are independently
associated with unfavorable prognosis in patients with acute
myeloid leukemia. Clin Lymphoma Myeloma Leuk. 13:686–692. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mills SC, Goh PH, Kudatsih J, Ncube S,
Gurung R, Maxwell W and Mueller A: Cell migration towards CXCL12 in
leukemic cells compared to breast cancer cells. Cell Signal.
28:316–324. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Okabe S, Fukuda S and Broxmeyer HE:
Activation of Wiskott-Aldrich syndrome protein and its association
with other proteins by stromal cell-o9 factor-1alpha isassociated
with cell migration in a T-lymphocyte line. Exp Hematol.
30:761–766. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Murata K, Kitaori T, Oishi S, Watanabe N,
Yoshitomi H, Tanida S, Ishikawa M, Kasahara T, Shibuya H, Fujii N,
et al: Stromal cell-derived factor 1 regulates the actin
organization of chondrocytes and chondrocyte hypertrophy. PLoS One.
7:e371632012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Vicente-Manzanares M, Cruz-Adalia A,
Martín-Cófreces NB, Cabrero JR, Dosil M, Alvarado-Sánchez B,
Bustelo XR and Sánchez-Madrid F: Control of lymphocyte shape and
the chemotactic response by the GTP exchange factor Vav. Blood.
105:3026–3034. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sessa WC: eNOS at a glance. J Cell Sci.
117:2427–2429. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xu W, Liu LZ, Loizidou M, Ahmed M and
Charles IG: The role of nitric oxide in cancer. Cell Res.
12:311–320. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Williams MS, Noguchi S, Henkart PA and
Osawa Y: Nitric oxide synthase plays a signaling role in
TCR-triggered apoptotic death. J Immunol. 161:6526–6531.
1998.PubMed/NCBI
|
|
23
|
Jadeski LC, Chakraborty C and Lala PK:
Nitric oxide-mediated promotion of mammary tumour cell migration
requires sequential activation of nitric oxide synthase, guanylate
cyclase and mitogen-activated protein kinase. Int J Cancer.
106:496–504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Beauvais F, Michel L and Dubertret L:
Exogenous nitric oxide elicits chemotaxis of neutrophils in vitro.
J Cell Physiol. 165:610–614. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Murohara T, Witzenbichler B, Spyridopoulos
I, Asahara T, Ding B, Sullivan A, Losordo DW and Isner JM: Role of
endothelial nitric oxide synthase in endothelial cell migration.
Arterioscler Thromb Vasc Biol. 19:1156–1161. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sarkar R, Meinberg EG, Stanley JC, Gordon
D and Webb RC: Nitric oxide reversibly inhibits the migration of
cultured vascular smooth muscle cells. Circ Res. 78:225–230. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Noiri E, Hu Y, Bahou WF, Keese CR, Giaever
I and Goligorsky MS: Permissive role of nitric oxide in
endothelin-induced migration of endothelial cells. J Biol Chem.
272:1747–1752. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cherla RP and Ganju RK: Stromal
cell-derived factor 1 alpha-induced chemotaxis in T cells is
mediated by nitric oxide signaling pathways. J Immunol.
166:3067–3074. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Guo D, Li JR, Wang Y, Lei LS, Yu CL and
Chen NN: Cyclovirobuxinum D suppresses lipopolysaccharide-induced
inflammatory responses in murine macrophages in vitro by blocking
JAK-STAT signaling pathway. Acta Pharmacol Sin. 35:770–778. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yu LY, Lin B, Zhang ZL and Guo LH: Direct
transfer of A20 gene into pancreas protected mice from
streptozotocin-induced diabetes. Acta Pharmacol Sin. 25:721–726.
2004.PubMed/NCBI
|
|
31
|
Bachelerie F, Ben-Baruch A, Burkhardt AM,
Combadiere C, Farber JM, Graham GJ, Horuk R, Sparre-Ulrich AH,
Locati M, Luster AD, et al: International Union of Basic and
Clinical Pharmacology. (corrected). LXXXIX. Update on the extended
family of chemokine receptors and introducing a new nomenclature
for atypical chemokine receptors. Pharmacol Rev. 66:1–79. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cheng M, Huang K, Zhou J, Yan D, Tang YL,
Zhao TC, Miller RJ, Kishore R, Losordo DW and Qin G: A critical
role of Src family kinase in SDF-1/CXCR4-mediated bone-marrow
progenitor cell recruitment to the ischemic heart. J Mol Cell
Cardiol. 81:49–53. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
De Luca A, D'Alessio A, Gallo M, Maiello
MR, Bode AM and Normanno N: Src and CXCR4 are involved in the
invasiveness of breast cancer cells with acquired resistance to
lapatinib. Cell Cycle. 13:148–156. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kim CH and Broxmeyer HE: Chemokines:
Signal lamps for trafficking of T and B cells for development and
effector function. J Leukoc Biol. 65:6–15. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gupta SK and Vlahakis NE: Integrin
alpha9beta1 mediates enhanced cell migration through nitric oxide
synthase activity regulated by Src tyrosine kinase. J Cell Sci.
122:2043–2054. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ambriz-Peña X, Garcia-Zepeda EA, Meza I
and Soldevila G: Jak3 enables chemokine-dependent actin
cytoskeleton reorganization by regulating cofilin and
Rac/RhoaGTPases activation. PLoS One. 9:e880142014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Serrador JM, Nieto M and Sánchez-Madrid F:
Cytoskeletal rearrangement during migration and activation of T
lymphocytes. Trends Cell Biol. 9:228–233. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Goligorsky MS, Abedi H, Noiri E, Takhtajan
A, Lense S, Romanov V and Zachary I: Nitric oxide modulation of
focal adhesions in endothelial cells. Am J Physiol.
276:C1271–C1281. 1999. View Article : Google Scholar : PubMed/NCBI
|
